Two siblings are evaluated for hyperammonemia. The elder brother (age 8) has a history of protein intolerance and developmental delay, with plasma ammonia 250 µmol/L and markedly elevated plasma argininosuccinate (180 µmol/L, normal <7). His younger sister (age 5) has similar symptoms but with plasma ammonia 200 µmol/L and normal argininosuccinate levels (4 µmol/L). Genetic testing confirms argininosuccinate lyase deficiency in the brother and argininosuccinate synthetase deficiency in the sister. Which laboratory finding best distinguishes argininosuccinate lyase deficiency from argininosuccinate synthetase deficiency?

Explanation

## Discriminating Argininosuccinate Lyase from Argininosuccinate Synthetase Deficiency ### Urea Cycle Position and Biochemistry **Key Point:** These two defects occur at consecutive steps in the urea cycle, but their substrate/product profiles are dramatically different. ```mermaid flowchart TD A[Citrulline + Aspartate]:::outcome --> B[Argininosuccinate Synthetase]:::action B --> C[Argininosuccinate]:::outcome C --> D[Argininosuccinate Lyase]:::action D --> E[Arginine + Fumarate]:::outcome E --> F[Arginine → Urea + Ornithine]:::action G[Synthetase Deficiency]:::urgent --> H[Argininosuccinate CANNOT form]:::outcome I[Lyase Deficiency]:::urgent --> J[Argininosuccinate ACCUMULATES]:::outcome ``` ### Biochemical Profiles **In Argininosuccinate Lyase Deficiency:** 1. Argininosuccinate synthetase works normally → argininosuccinate is produced 2. Argininosuccinate lyase is deficient → argininosuccinate CANNOT be cleaved to arginine + fumarate 3. **Argininosuccinate accumulates massively** in plasma and is excreted in urine (crystalline argininosuccinate in urine is pathognomonic) 4. Arginine production is blocked → arginine is low 5. Ammonia accumulates (cannot complete the cycle) 6. Urine orotic acid is **normal** (carbamoyl phosphate is not shunted to pyrimidine synthesis) **In Argininosuccinate Synthetase Deficiency (Citrullinemia Type I):** 1. Argininosuccinate synthetase is deficient → argininosuccinate CANNOT be formed 2. **Citrulline accumulates** (substrate of the blocked enzyme) → plasma and urine citrulline are markedly elevated 3. **Argininosuccinate is normal or low** (cannot form) 4. Arginine is low (cannot be produced) 5. Ammonia accumulates 6. Urine orotic acid is **normal** (carbamoyl phosphate is not shunted) ### Comparison Table | Feature | Argininosuccinate Lyase Deficiency | Argininosuccinate Synthetase Deficiency | |---------|-------------------------------------|------------------------------------------| | **Plasma Argininosuccinate** | **Markedly elevated (>100 µmol/L)** | Normal/low (<7 µmol/L) | | **Urine Argininosuccinate** | **Markedly elevated (crystalline)** | Normal/low | | **Plasma Citrulline** | Normal/low | **Markedly elevated (>100 µmol/L)** | | **Plasma Arginine** | Low | Low | | **Plasma Ammonia** | Elevated | Elevated | | **Urine Orotic Acid** | Normal | Normal | | **Clinical Name** | Argininosuccinic Aciduria | Citrullinemia Type I | | **Inheritance** | Autosomal recessive | Autosomal recessive | **High-Yield:** The **urine argininosuccinate crystal** (seen on microscopy or as a white crystalline precipitate) is virtually pathognomonic for argininosuccinate lyase deficiency and is a classic NEET PG finding. **Clinical Pearl:** Argininosuccinate lyase deficiency causes a distinctive odor in urine ("fruity" or "musty") due to argininosuccinate and is associated with trichomegaly (abnormally long eyelashes) — a rare but memorable clinical sign. ### Why Option 0 Is Correct The **markedly elevated plasma and urine argininosuccinate** is the pathognomonic discriminator for argininosuccinate lyase deficiency. This reflects the accumulation of the substrate that cannot be cleaved by the deficient enzyme. In contrast, argininosuccinate synthetase deficiency shows elevated citrulline (the substrate of the blocked enzyme), not argininosuccinate. [cite:Robbins 10e Ch 7]